Wüstenrot & Württembergische AG

  • WKN: 805100
  • ISIN: DE0008051004
  • Land: Deutschland

Nachricht vom 23.09.2020 | 09:42

Württembergische has new leadership

DGAP-News: Wüstenrot & Württembergische AG / Key word(s): Personnel
23.09.2020 / 09:42
The issuer is solely responsible for the content of this announcement.

Württembergische has new leadership

Zeliha Hanning as Chair of the Executive Board of the insurance company - Jacques Wasserfall to lead life insurance

Changes are coming in the Executive Boards of Württembergische insurance group. With effect from 1 January 2021, Zeliha Hanning (41) will take over as Chairwoman of the Executive Board of Württembergische Versicherung AG and Jacques Wasserfall (45) will be the new Chairman of the Executive Board of Württembergische Lebensversicherung AG and Württembergische Krankenversicherung AG. They will succeed Thomas Bischof (45), who is leaving the Group for family reasons. The personnel change remains subject to approval by the supervisory authorities.

Zeliha Hanning joined Württembergische Versicherung in 2000. She held numerous management positions in sales, among other positions. From 2016 to 2019 she was in charge of organisational design and IT management. Zeliha Hanning has been General Representative for the Private Clients Property and Casualty division and the Customer and Intermediary Services division since the end of 2019. In future, she will also be in charge of insurance sales in addition to her position as Chairwoman of the Executive Board.

Jacques Wasserfall joined Württembergische Lebensversicherung in July 2020 as a member of the Executive Board responsible for health insurance business. He was previously a member of the Executive Board of Zurich Deutscher Herold Lebensversicherung, and prior to that, worked as a senior actuary for various insurers starting in 1999. Jacques Wasserfall will in future be Chairman of the Executive Board of Württembergische Lebensversicherung and, following a corresponding board resolution, is to become Chairman of the Executive Board of Württembergische Krankenversicherung.

The Chairman of the Supervisory Board of Württembergische Versicherung and CEO of W&W AG, Jürgen A. Junker: "With Zeliha Hanning and Jacques Wasserfall, the management of our major companies that are so important for the future of the Group is gaining two compelling personalities. I am all the more pleased that both of them have previously demonstrated their abilities in-house. This also underlines the fact that the development of management staff, which we have established over the past few years, also means success for the leadership roles in the W&W Group." Junker adds: "I wish all the best to Mr Bischof. We respect his wish to leave Württembergische for family reasons, and thank him for his successful work."


23.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

Event im Fokus

Termine 2021

10. Juni 2021:Fachkonferenz Immobilien

14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure

13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie

10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix

„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“


Kaufen: Aspermont Limited hat Turnaround abgeschlossen

Aspermont Limited ist der weltweit führende Anbieter von Business-to-Business-Medien (B2B) für den Rohstoffsektor. Mit einem neuen Management hat das Unternehmen seit 2016 den erfolgreichen Turnaround von einem traditionellen Medienunternehmen zu einem digitalen B2B-XaaS-Geschäftsmodell umgesetzt. Das Unternehmen hat diesen Turnaround im GJ 2020 abgeschlossen, als es sein erstes positives EBITDA-Ergebnis verzeichnete. Auf der Grundlage unseres DCF-Modells haben wir ein Kursziel von 0,09 AUD (0,06 Euro) pro Aktie ermittelt und vergeben das Rating KAUFEN.

Aktueller Webcast

Stealth BioTherapeutics

Cantor Global Healthcare Conference Fireside Chat

30. September 2021

Aktuelle Research-Studie

MPH Health Care AG

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Buy

20. September 2021